Last reviewed · How we verify
trimetaphan — Competitive Intelligence Brief
unknown
Neuronal acetylcholine receptor subunit alpha-10, Neuronal acetylcholine receptor subunit alpha-7, Neuronal acetylcholine receptor; alpha3/beta4
Neuroscience
Live · refreshed every 30 min
Target snapshot
trimetaphan (trimetaphan).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| trimetaphan TARGET | trimetaphan | unknown | Neuronal acetylcholine receptor subunit alpha-10, Neuronal acetylcholine receptor subunit alpha-7, Neuronal acetylcholine receptor; alpha3/beta4 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- trimetaphan CI watch — RSS
- trimetaphan CI watch — Atom
- trimetaphan CI watch — JSON
- trimetaphan alone — RSS
Cite this brief
Drug Landscape (2026). trimetaphan — Competitive Intelligence Brief. https://druglandscape.com/ci/trimetaphan. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing